368 related articles for article (PubMed ID: 24247281)
1. Archaebiotics: proposed therapeutic use of archaea to prevent trimethylaminuria and cardiovascular disease.
Brugère JF; Borrel G; Gaci N; Tottey W; O'Toole PW; Malpuech-Brugère C
Gut Microbes; 2014; 5(1):5-10. PubMed ID: 24247281
[TBL] [Abstract][Full Text] [Related]
2. Archaea, specific genetic traits, and development of improved bacterial live biotherapeutic products: another face of next-generation probiotics.
Fadhlaoui K; Arnal ME; Martineau M; Camponova P; Ollivier B; O'Toole PW; Brugère JF
Appl Microbiol Biotechnol; 2020 Jun; 104(11):4705-4716. PubMed ID: 32281023
[TBL] [Abstract][Full Text] [Related]
3. Trimethylamine and Trimethylamine N-Oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and Disease.
Fennema D; Phillips IR; Shephard EA
Drug Metab Dispos; 2016 Nov; 44(11):1839-1850. PubMed ID: 27190056
[TBL] [Abstract][Full Text] [Related]
4. Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation.
Kuka J; Liepinsh E; Makrecka-Kuka M; Liepins J; Cirule H; Gustina D; Loza E; Zharkova-Malkova O; Grinberga S; Pugovics O; Dambrova M
Life Sci; 2014 Nov; 117(2):84-92. PubMed ID: 25301199
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of suspected trimethylaminuria by NMR spectroscopy.
Podadera P; Sipahi AM; Arêas JA; Lanfer-Marquez UM
Clin Chim Acta; 2005 Jan; 351(1-2):149-54. PubMed ID: 15563884
[TBL] [Abstract][Full Text] [Related]
6. Treatments of trimethylaminuria: where we are and where we might be heading.
Schmidt AC; Leroux JC
Drug Discov Today; 2020 Sep; 25(9):1710-1717. PubMed ID: 32615074
[TBL] [Abstract][Full Text] [Related]
7. Trimethylaminuria (fish odor syndrome): genotype characterization among Portuguese patients.
Ferreira F; Esteves S; Almeida LS; Gaspar A; da Costa CD; Janeiro P; Bandeira A; Martins E; Teles EL; Garcia P; Azevedo L; Vilarinho L
Gene; 2013 Sep; 527(1):366-70. PubMed ID: 23791655
[TBL] [Abstract][Full Text] [Related]
8. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.
Romano KA; Vivas EI; Amador-Noguez D; Rey FE
mBio; 2015 Mar; 6(2):e02481. PubMed ID: 25784704
[TBL] [Abstract][Full Text] [Related]
9. The use of an in-vitro batch fermentation (human colon) model for investigating mechanisms of TMA production from choline, L-carnitine and related precursors by the human gut microbiota.
Day-Walsh P; Shehata E; Saha S; Savva GM; Nemeckova B; Speranza J; Kellingray L; Narbad A; Kroon PA
Eur J Nutr; 2021 Oct; 60(7):3987-3999. PubMed ID: 33934200
[TBL] [Abstract][Full Text] [Related]
10. The complex metabolism of trimethylamine in humans: endogenous and exogenous sources.
Chhibber-Goel J; Gaur A; Singhal V; Parakh N; Bhargava B; Sharma A
Expert Rev Mol Med; 2016 Apr; 18():e8. PubMed ID: 27126549
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing.
Guo Y; Hwang LD; Li J; Eades J; Yu CW; Mansfield C; Burdick-Will A; Chang X; Chen Y; Duke FF; Zhang J; Fakharzadeh S; Fennessey P; Keating BJ; Jiang H; Hakonarson H; Reed DR; Preti G
BMC Med Genet; 2017 Feb; 18(1):11. PubMed ID: 28196478
[TBL] [Abstract][Full Text] [Related]
12. Trimethylamine/Trimethylamine-N-Oxide as a Key Between Diet and Cardiovascular Diseases.
He S; Jiang H; Zhuo C; Jiang W
Cardiovasc Toxicol; 2021 Aug; 21(8):593-604. PubMed ID: 34003426
[TBL] [Abstract][Full Text] [Related]
13. [Trimethylaminuria: fish-odor syndrome].
Sela BA; Trau H; Spira A
Harefuah; 1993 Feb; 124(3):138-9, 183. PubMed ID: 8495879
[TBL] [Abstract][Full Text] [Related]
14. Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota.
Hoyles L; Jiménez-Pranteda ML; Chilloux J; Brial F; Myridakis A; Aranias T; Magnan C; Gibson GR; Sanderson JD; Nicholson JK; Gauguier D; McCartney AL; Dumas ME
Microbiome; 2018 Apr; 6(1):73. PubMed ID: 29678198
[TBL] [Abstract][Full Text] [Related]
15. Trigonelline inhibits intestinal microbial metabolism of choline and its associated cardiovascular risk.
Anwar S; Bhandari U; Panda BP; Dubey K; Khan W; Ahmad S
J Pharm Biomed Anal; 2018 Sep; 159():100-112. PubMed ID: 29980011
[TBL] [Abstract][Full Text] [Related]
16. Effects of the dietary supplements, activated charcoal and copper chlorophyllin, on urinary excretion of trimethylamine in Japanese trimethylaminuria patients.
Yamazaki H; Fujieda M; Togashi M; Saito T; Preti G; Cashman JR; Kamataki T
Life Sci; 2004 Apr; 74(22):2739-47. PubMed ID: 15043988
[TBL] [Abstract][Full Text] [Related]
17. FMO3 allelic variants in Sicilian and Sardinian populations: trimethylaminuria and absence of fish-like body odor.
D'Angelo R; Esposito T; Calabrò M; Rinaldi C; Robledo R; Varriale B; Sidoti A
Gene; 2013 Feb; 515(2):410-5. PubMed ID: 23266626
[TBL] [Abstract][Full Text] [Related]
18. [Primary trimethylaminuria: the fish odor syndrome].
Montoya Alvarez T; Guardiola PD; Roldán JO; Elviro R; Wevers R; Guijarro G
Endocrinol Nutr; 2009; 56(6):337-40. PubMed ID: 19695515
[TBL] [Abstract][Full Text] [Related]
19. Lactobacillus plantarum ZDY04 exhibits a strain-specific property of lowering TMAO via the modulation of gut microbiota in mice.
Qiu L; Tao X; Xiong H; Yu J; Wei H
Food Funct; 2018 Aug; 9(8):4299-4309. PubMed ID: 30039147
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and phenotypic assessment of trimethylaminuria, and its treatment with riboflavin:
Bouchemal N; Ouss L; Brassier A; Barbier V; Gobin S; Hubert L; de Lonlay P; Le Moyec L
Orphanet J Rare Dis; 2019 Sep; 14(1):222. PubMed ID: 31533761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
